← Eichor
Study identifier: NCT07264452 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Comparison of the Efficacy of Accelerated Intermittent Theta Burst Stimulation and Accelerated Continuous Theta Burst Stimulation in Patients With Treatment-Resistant Depression

Condition: Treatment Resistant Depression (TRD) · Transcranial Magnetic Stimulation · Accelerated Protocol  ·  Sponsor: Ataturk University

PhaseNA
Planned participants60
Who can joinAll sexes, 18 Years to 65 Years
Healthy volunteersYes

About this study

In recent years, research on the effectiveness of transcranial magnetic stimulation (TMS) in patients with treatment-resistant depression (RTD) has been steadily increasing. The aim of this study was to examine the effectiveness of accelerated unilateral application of two different forms of theta burst stimulation (TBU), a variation of repetitive TMU (rTMS)-intermittent TBU (iTBU) and continuous TBU (cTBU)-in TDD patients. The study aimed to compare the advantages of iTBU and cTBU protocols on depression, suicidal thoughts, anxiety levels, sleep disturbances, cognitive performance, and overall functioning following a two-week intensive treatment period and a 12-week follow-up period.

This description comes directly from the study's public registry record.

Talk to the study team

Mahmut Balamur, research assistant doctor  ·  +905350705623  ·  m.balamur5@gmail.com

Omer Faruk UYGUR, Associate professor doctor  ·  +905456161625  ·  drofuygur@hotmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Ataturk UniversityErzurum, Turkey (Türkiye)Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07264452